An in vivo assay for osteoclast activity using mouse calvaria

Abstract

Osteoclasts are essential for maintaining healthy bone. Pathological elevation of osteoclastogenesis or osteoclast activity can cause osteoporosis and increase the risk of bone fracture. However, a few options are available for directly measuring osteoclast activity in vivo to test interventions that may affect osteoclasts. Here, we describe an in vivo method to measure osteoclast-mediated bone loss targeted at normal mouse calvaria. The method employs a novel procedure for measuring osteoclast resorption pits using micro-computed tomography. The potential utility of this mouse calvaria model to assess therapies targeting osteoclasts was validated using zoledronic acid, which is a nitrogen-containing bisphosphonate drug used to treat osteoporosis.

Keywords

bone / mouse model / osteoclast / osteoporosis / resorption assay

References

[1] Kim JM, Lin C, Stavre Z, Greenblatt MB, Shim JH. Osteoblast-osteoclast communication and bone homeostasis. Cells. 2020; 9(9):2073.

[2] Matikainen N, Pekkarinen T, Ryhänen EM, Schalin-Jäntti C. Physiology of calcium homeostasis: an overview. Endocrinol Metab Clin N Am. 2021; 50(4): 575-590.

[3] Florencio-Silva R, da Silva Sasso GR, Sasso-Cerri E, Simões MJ, Sérgio Cerri P. Biology of bone tissue: structure, function, and factors that influence bone cells. Biomed Res Int. 2015; 2015:421746.

[4] Teitelbaum SL, Ross FP. Genetic regulation of osteoclast development and function. Nat Rev Genet. 2003; 4(8): 638-649.

[5] Boyde A, Ali NN, Jones SJ. Resorption of dentine by isolated osteoclasts in vitro. Br Dent J. 1984; 156(6): 216-220.

[6] Kikuiri T, Yoshimura Y, Tabata F, Hasegawa T, Nishihira J, Shirakawa T. Stage-dependent suppression of the formation of dentin-resorbing multinuclear cells with migration inhibitory factor in vitro. Exp Ther Med. 2012; 3(1): 37-43.

[7] Rumpler M, Würger T, Roschger P, et al. Osteoclasts on bone and dentin in vitro: mechanism of trail formation and comparison of resorption behavior. Calcif Tissue Int. 2013; 93(6): 526-539.

[8] Schwartz Z, Lohmann CH, Wieland M, et al. Osteoblast proliferation and differentiation on dentin slices are modulated by pretreatment of the surface with tetracycline or osteoclasts. J Periodontol. 2000; 71(4): 586-597.

[9] Roelofs AJ, Stewart CA, Sun S, et al. Influence of bone affinity on the skeletal distribution of fluorescently labeled bisphosphonates in vivo. J Bone Miner Res. 2012; 27(4): 835-847.

[10] Sprague JE, Kitaura H, Zou W, et al. Noninvasive imaging of osteoclasts in parathyroid hormone-induced osteolysis using a 64Cu-labeled RGD peptide. J Nucl Med. 2007; 48(2): 311-318.

[11] Hillam RA, Skerry TM. Inhibition of bone resorption and stimulation of formation by mechanical loading of the modeling rat ulna in vivo. J Bone Miner Res. 1995; 10(5): 683-689.

[12] Kim H, Lee YD, Kim HJ, Lee ZH, Kim HH. SOD2 and Sirt3 control Osteoclastogenesis by regulating mitochondrial ROS. J Bone Miner Res. 2017; 32(2): 397-406.

[13] Lam J, Nelson CA, Ross FP, Teitelbaum SL, Fremont DH. Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity. J Clin Invest. 2001; 108(7): 971-979.

[14] McHugh KP, Hodivala-Dilke K, Zheng MH, et al. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest. 2000; 105(4): 433-440.

[15] Koh BI, Mohanakrishnan V, Jeong HW, et al. Adult skull bone marrow is an expanding and resilient haematopoietic reservoir. Nature. 2024; 636(8041): 172-181.

[16] Li B, Li J, Fan Y, et al. Dissecting calvarial bones and sutures at single-cell resolution. Biol Rev Camb Philos Soc. 2023; 98(5): 1749-1767.

[17] Novak S, Roeder E, Kalinowski J, et al. Osteoclasts derive predominantly from bone marrow-resident CX(3)CR1(+) precursor cells in homeostasis, whereas circulating CX(3)CR1(+) cells contribute to osteoclast development during fracture repair. J Immunol. 2020; 204(4): 868-878.

[18] Speziani C, Rivollier A, Gallois A, et al. Murine dendritic cell transdifferentiation into osteoclasts is differentially regulated by innate and adaptive cytokines. Eur J Immunol. 2007; 37(3): 747-757.

[19] Udagawa N, Takahashi N, Akatsu T, et al. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA. 1990; 87(18): 7260-7264.

[20] Lee YD, Kim B, Jung S, et al. The dynactin subunit DCTN1 controls osteoclastogenesis via the Cdc42/PAK2 pathway. Exp Mol Med. 2020; 52(3): 514-528.

[21] Yoon SH, Lee Y, Kim HJ, et al. Lyn inhibits osteoclast differentiation by interfering with PLCgamma1-mediated Ca²⁺ signaling. FEBS Lett. 2009; 583(7): 1164-1170.

[22] Lorenzo J. Sexual dimorphism in osteoclasts. Cells. 2020; 9(9):2086.

[23] Zanotti S, Kalajzic I, Aguila HL, Canalis E. Sex and genetic factors determine osteoblastic differentiation potential of murine bone marrow stromal cells. PLoS One. 2014; 9(1):e86757.

[24] Abe K, Aoki Y. Sex differences in bone resorption in the mouse femur. A light- and scanning electron-microscopic study. Cell Tissue Res. 1989; 255(1): 15-21.

[25] Kameda T, Mano H, Yuasa T, et al. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med. 1997; 186(4): 489-495.

[26] Martin-Millan M, Almeida M, Ambrogini E, et al. The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol Endocrinol. 2010; 24(2): 323-334.

[27] Bell MR. Comparing postnatal development of gonadal hormones and associated social behaviors in rats, mice, and humans. Endocrinology. 2018; 159(7): 2596-2613.

[28] Ahima RS, Dushay J, Flier SN, Prabakaran D, Flier JS. Leptin accelerates the onset of puberty in normal female mice. J Clin Invest. 1997; 99(3): 391-395.

[29] Kuritani M, Sakai N, Karakawa A, et al. Anti-mouse RANKL antibodies inhibit alveolar bone destruction in periodontitis model mice. Biol Pharm Bull. 2018; 41(4): 637-643.

RIGHTS & PERMISSIONS

2025 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.